Predictive Value of Gastrointestinal Blood Flow for Enteral Nutrition Intolerance in Critically Ill Patients

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorRuijin Hospital

About this trial

This study aims to explore the correlation between gastrointestinal blood flow and the incidence of enteral nutrition intolerance (ENI) and its symptoms in critically ill patients, construct and compare predictive models including blood flow parameters, and evaluate their incremental predictive value.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age > 18 years old.

Expected duration of enteral nutrition support > 7 days.

Patients or their legal representatives sign the informed consent form.

Disqualifiers

History of major gastrointestinal surgery such as subtotal gastrectomy and gastrointestinal anastomosis.

Contraindications to abdominal point-of-care ultrasound (POCUS) examination (e.g., recent large-area abdominal burns, dressings blocking movement, open abdomen).

Presence of severe gastrointestinal diseases such as gastroparesis, intestinal obstruction, digestive tract perforation, and gastrointestinal bleeding upon admission.

Presence of severe peripheral vascular disease or valvular heart disease.

Trial population

Adult critically ill patients admitted to the Intensive Care Units (ICUs) of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine. These patients require continuous enteral nutrition support with an expected duration of more than 7 days.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

500 Participants
are grouped into 1 trial group
Group A: Critically ill patients

Trial outcomes

Primary outcomes

1

Incidence of Enteral Nutrition Intolerance

The rate of enteral nutrition intolerance occurs during the first 7 days of enteral nutrition support.

Time frame
Assessed daily from Day 1 to Day 7 of enteral nutrition

Secondary outcomes

1

Incidence of gastrointestinal symptoms

The rate of gastrointestinal symptoms, including reflux, vomiting, aspiration, diarrhea, delayed gastric emptying, and abdominal distension

Time frame
Assessed daily from Day 1 to Day 7 of enteral nutrition
2

Achievement rate of targeted feeding volume

The rate of achieving 80% of the target feeding volume

Time frame
Assessed daily from Day 1 to Day 7 of enteral nutrition
3

Length of ICU stay

Time frame
Until ICU discharge, up to 28 days
4

28-day mortality rate

Time frame
up to day 28 post-ICU admission

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.